Metabolic Responses of Extracellular Matrix in Tissue Repair

References

• Sun Y, Ratajska A, Zhou G, Weber K T. Angiotensin converting enzyme and myocardial fibrosis in the rat receiving angiotensin II or aldosterone. J Lab Clin Med 1993; 122: 395–403
   PubMed Web of Science ®Google Scholar
• Sun Y, Weber K T. Angiotensin II and aldosterone receptor binding in rat heart and kidney: response to chronic angiotensin II or aldosterone administration. J Lab Clin Med 1993; 122: 404–11
   PubMed Web of Science ®Google Scholar
• Sun Y, Weber K T. Nonendothelial ACE and myocardial fibrosis in rats receiving angiotensin II: inhibition by lisino-pril. Am J Hypertens 1993; 6: 4A, (Abstr)
   Google Scholar
• Sun Y, Ratajska A, Weber K T. Bradykinin receptor and tissue ACE binding in myocardial fibrosis: response to chronic angiotensin II or aldosterone administration in rats. J Mol Cell Cardiol 1995; 27: 813–22
   PubMedGoogle Scholar
• Sun Y, Diaz-Arias A A, Weber K T. Angiotensin-converting enzyme, bradykinin and angiotensin II receptor binding in rat skin, tendon and heart valves: an in vitro quantitative autoradiographic study. J Lab Clin Med 1994; 123: 372–7
   PubMedGoogle Scholar
• Sun Y, Cleutjens J PM, Diaz-Arias A A, Weber K T. Cardiac angiotensin converting enzyme and myocardial fibrosis in the rat. Cardiovasc Res 1994; 28: 1423–32
   PubMed Web of Science ®Google Scholar
• Yamada H, Fabris B, Allen A M, Jackson B, Johnston C I, Mendelsohn F AO. Localization of angiotensin converting enzyme in rat heart. Circ Res 1991; 68: 141–9
   PubMed Web of Science ®Google Scholar
• Pinto J E, Viglione P, Saavedra J M. Autoradiographic localization and quantification of rat heart angiotensin converting enzyme. Am J Hypertens 1991; 4: 321–6
   PubMedGoogle Scholar
• Bashey Rl, Torii S, Angrist A. Age-related collagen and elastin content of human heart valves. J Gerontol 1967; 22: 203–8
   PubMedGoogle Scholar
• Katwa L C, Tyagi S C, Campbell S E, Lee S J, Cicila G T, Weber K T. Valvular interstitial cells express angiotensi-nogen, cathepsin D, and generate angiotensin peptides. Int J Biochem Cell Biol 1996; 28: 807–21
   PubMed Web of Science ®Google Scholar
• Filip D A, Radu A, Simionescu M. Interstitial cells of the heart valves possess characteristics similar to smooth muscle cells. Circ Res 1986; 59: 310–20
   PubMed Web of Science ®Google Scholar
• Katwa L C, Ratajska A, Cleutjens J PM, et al. Angiotensin converting enzyme and kininase-ll-like activities in cultured valvular interstitial cells of the rat heart. Cardiovasc Res 1995; 29: 57–64
   PubMedGoogle Scholar
• Hara A, Fukuyama K, Epstein M L. Partial purification and characterization of angiotensin-converting enzyme in mouse and human skin. J Invest Dermatol 1982; 78: 503–7
   PubMed Web of Science ®Google Scholar
• Keeley F W, Elmoselhi A, Leenen F HH. Enalapril suppresses normal accumulation of elastin and collagen in cardiovascular tissues of growing rats. Am J Physiol 1992; 262: H1013–21
   PubMed Web of Science ®Google Scholar
• Albaladejo P, Bouaziz H, Duriez M, et al. Angiotensin converting enzyme inhibition prevents the increase in aortic collagen in rats. Hypertension 1994; 23: 74–82
   PubMedGoogle Scholar
• Johnston C I, Mooser V, Sun Y, Fabris B. Changes in cardiac angiotensin converting enzyme after myocardial infarction and hypertrophy in rats. Clin Exp Pharmacol Physiol 1991; 18: 107–10
   PubMed Web of Science ®Google Scholar
• Fabris B, Jackson B, Kohzuki M, Perich R, Johnston C I. Increased cardiac angiotensin-converting enzyme in rats with chronic heart failure. Clin Exp Pharmacol Physiol 1990; 17: 309–14
   PubMedGoogle Scholar
• Volders P GA, Willems I EMG, Cleutjens J PM, Arends J -W, Havenlth M G, Daemen M JAP. Interstitial collagen is increased in the non-infarcted human myocardium after myocardial infarction. J Mol Cell Cardiol 1993; 25: 1317–23
   PubMedGoogle Scholar
• van Krimpen C, Schoemaker R G, Cleutjens J PM, et al. Angiotensin I converting enzyme inhibitors and cardiac remodeling. Basic Res Cardiol 1991; 86(Suppl 1)149–55
   PubMedGoogle Scholar
• Sun Y, Ratajska A, Weber K T. Inhibition of angiotensin-converting enzyme and attenuation of myocardial fibrosis by lisinopril in rats receiving angiotensin II. J Lab Clin Med 1995; 126: 95–101
   PubMedGoogle Scholar
• Cleutjens J PM, Verluyten M JA, Smits J FM, Daemen M JAP. Collagen remodeling after myocardial infarction in the rat heart. Am J Pathol 1995; 147: 325–38
   PubMed Web of Science ®Google Scholar
• Sun Y, Ramires F JA, Weber K T. Fibrosis of atria and great vessels in response to angiotensin II or aldosterone infusion. Circulation 1996; 94: I-659, (Abstr)
   Google Scholar
• Campbell S E, Janlcki J S, Weber K T. Temporal differences in fibroblast proliferation and phenotype expression in response to chronic administration of angiotensin II or aldosterone. J Mol Cell Cardiol 1995; 27: 1545–60
   PubMedGoogle Scholar
• Campbell D J, Habener J F. Cellular localization of angio-tensinogen gene expression in brown adipose tissue and mesentery: quantification of messenger ribonucleic acid abundance using hybridization. in situ. Endocrinology 1987; 121: 1616–26
   PubMed Web of Science ®Google Scholar
• Cassis L A, Lynch K R, Peach M J. Localization of angio-tensinogen messenger RNA in rat aorta. Circ Res 1988; 62: 1259–62
   PubMed Web of Science ®Google Scholar
• Lindpaintner K, Lu W, Niedermajer J, et al. Selective activation of cardiac angiotensinogen gene expression in post-infarction ventricular remodeling in the rat. J Mol Cell Cardiol 1993; 25: 133–43
   PubMed Web of Science ®Google Scholar
• Katwa L C, Campbell S E, Tyagi S C, Lee S J, Cicila G T, Weber K T. Cultured myofibroblasts generate angiotensin peptides. de novo. J Mol Cell Cardiol 1997; 29: 1375–86
   PubMed Web of Science ®Google Scholar
• Yamagishi H, Kim S, Nishikimi T, Takeuchi K, Takeda T. Contribution of cardiac renin-angiotensin system to ventricular remodelling in myocardial-infarcted rats. J Mol Cell Cardiol 1993; 25: 1369–80
   PubMedGoogle Scholar
• Hodsman G P, Kohzuki M, Howes L G, Sumithran E, Tsunoda K, Johnston C I. Neurohumoral responses to chronic myocardial infarction in rats. Circulation 1988; 78: 376–81
   PubMedGoogle Scholar
• Hirsch A T, Talsness C E, Schunkert H, Paul M, Ozau V J. Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure. Circ Res 1991; 69: 475–82
   PubMed Web of Science ®Google Scholar
• Studer R, Reinecke H, Muller B, Holtz J, Just H, Drexler H. Increased angiotensin-l converting enzyme gene expression in the failing human heart. Quantification by competitive RNA polymerase chain reaction. J Clin Invest 1994; 94: 301–10
   PubMed Web of Science ®Google Scholar
• Hokimoto S, Yasue H, Fujimoto K, Sakata R, Miyamoto E. Increased angiotensin converting enzyme activity in left ventricular aneurysm of patients after myocardial infarction. Cardiovasc Res 1995; 29: 664–9
   PubMedGoogle Scholar
• Ou R, Sun Y, Ganjam V K, Weber K T. In situ production of angiotensin II by fibrosed rat pericardium. J Mol Cell Cardiol 1996; 28: 1319–27
   PubMed Web of Science ®Google Scholar
• Nio Y, Matsubara H, Murasawa S, Kanasaki M, Inada M. Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction. J Clin Invest 1995; 95: 46–54
   PubMed Web of Science ®Google Scholar
• Makino N, Hata T, Sugano M, Dixon I MC, Yanaga T. Regression of hypertrophy after myocardial infarction is produced by the chronic blockade of angiotensin type I receptor in rats. J Mol Cell Cardiol 1996; 28: 507–17
   PubMed Web of Science ®Google Scholar
• Sun Y, Weber K T. Angiotensin II receptor binding following myocardial infarction in the rat. Cardiovasc Res 1994; 28: 1623–8
   PubMedGoogle Scholar
• Lefroy D C, Wharton J, Crake T, et al. Regional changes in angiotensin II receptor density after experimental myocardial infarction. J Mol Cell Cardiol 1996; 28: 429–40
   PubMedGoogle Scholar
• Stauss H M, Zhu Y C, Redlich T, Unger T. Early and late treatment of infarction-induced heart failure with a converting enzyme inhibitor: bradykinin potentiation versus angiotensin II reduction. Hypertension 1993; 22: 429, Abstr
   Web of Science ®Google Scholar
• Frimm C C de, Sun Y, Weber K T. Angiotensin II receptor blockade and myocardial fibrosis of the infarcted rat heart. J Lab Clin Med 1997; 129: 439–46
   PubMedGoogle Scholar
• Jugdutt Bl, Humen D P, Khan M I, Schwarz-Michorowski B L. Effect of left ventricular unloading with captopril on remodeling and function during healing of anterior transmural myocardial infarction in the dog. Can J Cardiol 1992; 8: 151–63
   PubMedGoogle Scholar
• Jugdutt Bl, Khan Ml, Jugdutt S J, Blinston G E. Effect of enalapril on ventricular remodeling and function during healing after anterior myocardial infarction in the dog. Circulation 1995; 91: 802–12
   PubMedGoogle Scholar
• Michel J -B, Lattion A -L, Salzmann J -L, et al. Hormonal and cardiac effects of converting enzyme inhibition in rat myocardial infarction. Circ Res 1988; 62: 641–50
   PubMed Web of Science ®Google Scholar
• Smits J FM, van Krimpen C, Schoemaker R G, Cleutjens J PM, Daemen M JAP. Angiotensin II receptor blockade after myocardial infarction in rats: effects on hemody namics, myocardial DNA synthesis, and interstitial collagen content. J Cardiovasc Pharmacol 1992; 20: 772–8
   PubMed Web of Science ®Google Scholar
• Pimentel J L, Jr, Sundell C L, Wang S, Kopp J B, Montero A, Martinez-Maldonado M. Role of angiotensin II in the expression and regulation of transforming growth factor-β in obstructive nephropathy. Kidney Int 1995; 48: 1233–46
   PubMedGoogle Scholar
• Morrissey J J, Ishidoya S, McCracken R, Klahr S. The effect of ACE inhibitors on the expression of matrix genes and the role of p53 and p21 (WAF1) in experimental renal fibrosis. Kidney Int 1996; 49(Suppl 54)S83–7
   Google Scholar
• Ishidoya S, Morrissey J, McCracken R, Reyes A, Klahr S. Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction. Kidney Int 1995; 47: 1285–94
   PubMed Web of Science ®Google Scholar
• Kaneto H, Morrissey J, McCracken R, Reyes A, Klahr S. Enalapril reduces collagen type IV synthesis and expansion of the interstitium in the obstructed rat kidney. Kidney Int 1994; 45: 1637–47
   PubMed Web of Science ®Google Scholar
• Pimentel J L, Jr, Martinez-Maldonado M, Wilcox J N, Wang S, Luo C. Regulation of renin-angiotensin system in unilateral ureteral obstruction. Kidney Int 1993; 44: 390–400
   PubMed Web of Science ®Google Scholar
• Ishidoya S, Morrissey J, McCracken R, Klahr S. Delayed treatment with enalapril halts tubulointerstitial fibrosis in rats with obstructive nephropathy. Kidney Int 1996; 49: 1110–9
   PubMed Web of Science ®Google Scholar
• Yanagisawa H, Morrissey J, Morrison A R, Klahr S. Eicosanoid production by isolated glomeruli of rats with unilateral ureteral obstruction. Kidney Int 1990; 37: 1528–35
   PubMedGoogle Scholar
• Diamond J R, Anderson S. Irreversible tubulointerstitial damage associated with chronic aminonucleoside nephrosis. Am J Pathol 1990; 137: 1323–32
   PubMed Web of Science ®Google Scholar
• Lafayette R A, Mayer G, Meyer T W. The effects of blood pressure reduction on cyclosporine nephrotoxicity in the rat. J Am Soc Nephrol 1993; 3: 1892–9
   PubMedGoogle Scholar
• Cohen E P, Moulder J E, Fish B L, Hill P. Prophylaxis of experimental bone marrow transplant nephropathy. J Lab Clin Med 1994; 124: 371–80
   PubMed Web of Science ®Google Scholar
• Tanaka R, Sugihara K, Tatematsu A, Fogo A. Inter-nephron heterogeneity of growth factors and sclerosis -modulation of platelet-derived growth factor by angiotensin II. Kidney Int 1995; 47: 131–9
   PubMedGoogle Scholar
• Ikoma M, Kawamura T, Kakinuma Y, Fogo A, Ichikawa I. Cause of variable therapeutic efficiency of angiotensin converting enzyme inhibitor on glomerular lesions. Kidney Int 1991; 40: 195–202
   PubMed Web of Science ®Google Scholar
• Shibouta Y, Chatani F, Ishimura Y, et al. TCV-116 inhibits renal interstitial and glomerular injury in glomerulosclerotic rats. Kidney Int 1996; 49(Suppl 55)S115–8
   Google Scholar
• Anderson S, Rennke H G, Brenner B M. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 1986; 77: 1993–2000
   PubMed Web of Science ®Google Scholar
• Juncos L I, Carrasco Duenas S, Cornejo J C, Broglia C A, Cejas H. Long-term enalapril and hydrochlorothiazide in radiation nephritis. Nephron 1993; 64: 249–55
   PubMed Web of Science ®Google Scholar
• Nakamura T, Honma H, Ikeda Y, et al. Renal protective effects of angiotensin II receptor I antagonist CV-11974 in spontaneously hypertensive stroke-prone rats (SHR-sp). Blood Press 1994; 3(Suppl 5)61–6
   Google Scholar
• Nakamura T, Obata J, Kuroyanagi R, et al. Involvement of angiotensin II in glomerulosclerosis of stroke-prone spontaneously hypertensive rats. Kidney Int 1996; 49(Suppl 55)S109–12
   Google Scholar
• Kim S, Ohta K, Hamaguchl A, et al. Contribution of renal angiotensin II type I receptor to gene expressions in hypertension-induced renal injury. Kidney Int 1994; 46: 1346–58
   PubMed Web of Science ®Google Scholar
• Kim S, Ohta K, Hamaguchi A, et al. Angiotensin II type I receptor antagonist inhibits the gene expression of transforming growth factor-β1 and extracellular matrix in cardiac and vascular tissues of hypertensive rats. J Pharmacol Exp Ther 1995; 273: 509–15
   PubMed Web of Science ®Google Scholar
• Ward W F, Molteni A, Ts'ao C. Radiation-induced endothelial dysfunction and fibrosis in rat lung: modification by the angiotensin converting enzyme inhibitor CL242817. Radiat Res 1989; 117: 342–50
   PubMed Web of Science ®Google Scholar
• Ward W F, Molteni A, Ts'ao C, Kim Y T, Hinz J M. Radiation pneumotoxicity in rats: modification by inhibitors of angiotensin converting enzyme. Int J Radiat Oncol Biol Phys 1992; 22: 623–5
   PubMedGoogle Scholar
• Ward W F, Molteni A, Ts'ao C -H, Hinz J M. Captopril reduces collagen and mast cell accumulation in irradiated rat lung. Int J Radiat Oncol Biol Phys 1990; 19: 1405–9
   PubMed Web of Science ®Google Scholar
• Molteni A, Ward W F, Ts'ao C, Soliday N H, Dunnes M. Monocrotaline-induced pulmonary fibrosis in rats: amelioration by captopril and penicillamine. Proc Soc Exp Biol Med 1985; 180: 112–20
   PubMed Web of Science ®Google Scholar
• Zhou G, Kandala J C, Tyagi S C, Katwa L C, Weber K T. Effects of angiotensin II and aldosterone on collagen gene expression and protein turnover in cardiac fibroblasts. Mol CellBiochem 1996; 154: 171–8
   Google Scholar
• Villarreal F J, Kim N N, Ungab G D, Printz M P, Dillmann W H. Identification of functional angiotensin II receptors on rat cardiac fibroblasts. Circulation 1993; 88: 2849–61
   PubMed Web of Science ®Google Scholar
• Brilla C G, Zhou G, Matsubara L, Weber K T. Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone. J Mol Cell Cardiol 1994; 26: 809–20
   PubMed Web of Science ®Google Scholar
• Riches D WH. Macrophage involvement in wound repair, remodeling, and fibrosis. The Molecular and Cellular Biology of Wound Repair, 2nd edn., R AF Clark. Plenum Press, New York 1996; 95–141
   Google Scholar
• Casscells W, Bazoberry F, Speir E, et al. Transforming growth factor-β1 in normal heart and in myocardial infarction. Ann NY Acad Sci 1990; 593: 148–60
   PubMedGoogle Scholar
• Hanatani A, Yoshlyama M, Kim S, et al. Inhibition by angiotensin II type 1 receptor antagonist of cardiac pheno-typic modulation after myocardial infarction. J Mol Cell Cardiol 1995; 27: 1905–14
   PubMedGoogle Scholar
• Lee A A, Dillmann W H, McCulloch A D, Villarreal F J. Angiotensin II stimulates the autocrine production of transforming growth factor-β1 in adult rat cardiac fibroblasts. J Mol Cell Cardiol 1995; 27: 2347–57
   PubMedGoogle Scholar
• Desmouliere A, Gabbiani G. The role of the myofibroblast in wound healing and fibrocontractive diseases. The Molecular and Cellular Biology of Wound Repair, 2nd edn., R AF Clark. Plenum Press, New York 1996; 391–423
   Google Scholar
• Peterson K E, Braley-Mullen H. Suppression of murine experimental autoimmune thyroiditis by oral administration of porcine thyroglobulin. Cell Immunol 1995; 166: 123–30
   PubMedGoogle Scholar
• Friedman S L. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med 1993; 328: 1828–35
   PubMed Web of Science ®Google Scholar
• Zhang G, Moorhead P J, el Nahas A M. Myofibroblasts and the progression of experimental glomerulonephritis. Exp Nephrol 1995; 3: 308–18
   PubMedGoogle Scholar
• Willems I EMG, Havenith M G, De Mey J GR, Daemen M JAP. The α-smooth muscle actin-positive cells in healing human myocardial scars. Am J Pathol 1994; 145: 868–75
   PubMed Web of Science ®Google Scholar